Search results
Analysis | Wyden demands penalties for Obamacare enrollment fraud
Washington Post· 1 day agoThe Health Brief is copying Congress and taking Friday off. Today’s edition: An industry group...
JBS says China blocks beef from US plant over detection of ractopamine
Reuters via AOL· 2 days agoBrazil-based JBS, the world's largest beef producer, said in a statement it is working with U.S. and...
CDC calls risk low, but is preparing against easier bird flu spread to people
Deseret News via Yahoo News· 7 days agoFood and Drug Administration, USDA and CDC in early May. “It is critical that you work swiftly ...
Apricot Power refuses to recall toxic apricot seeds
Consumer Affairs· 7 days agoApricot Power is refusing to recall apricot seeds after the U.S. Food and Drug Administration found they were toxic ...
Matthew Perry and the ketamine boom: Expensive, dangerous and very 'en vogue'
LA Times via Yahoo News· 2 days ago"People are going to look at it and say, was that prescription justified?" he said. Read more: High...
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND...
The Pilot News· 18 hours agoIf approved, the investigational therapy would offer a new treatment option for patients with advanced gastric and gastroesophageal junction cancers as ...
Nut recall update as FDA issues most serious concern level
Newsweek· 2 days agoThe voluntary recall of some of Gibson Farms' Organic Light halves and pieces shelled walnuts in...
Designating a Platform Technology: FDA’s Long-Awaited Draft Guidance | JD Supra
JD Supra· 2 days agoIn newly released Draft Guidance from the U.S. Food and Drug Administration (FDA) entitled, Platform Technology Designation ...
Matthew Perry and the ketamine boom: Expensive, dangerous and very 'en vogue'
Los Angeles Times· 2 days agoPerry’s death — now the subject of an investigation by the Los Angeles Police Department and the ...
U.S. FDA set to reorganize its food division starting October
AOL· 1 day agoThe regulatory body had come under fire over its slow response to the infant formula shortage in 2022. The FDA said the reorganization will enable it to be more efficient and agile while regulating the industry.